Quality-by-Design (QbD) Round Table Discussion Session: An Integrated and Science-Based Approach for Quality by Design (QbD) Implementation in Pharmaceutical Industry

Chair(s):
Wu, H., FDA
Co-chair(s):
Seymour, C., Pfizer

As the FDA and the pharmaceutical industry work together to embrace the shift of pharmaceutical quality regulation towards Quality-by-Design (QbD), significant efforts and progress have been made in various CMC areas of pharmaceutical development, scale-up, manufacturing process control, instrumentations, etc. The invited speakers for this session will present real world case examples to share successful experiences and lessons learned, and to discuss challenges and opportunities associated with the implementation of QbD in the pharmaceutical community. An in-depth Q&A following the presentations should stimulate innovative ideas and strategies in the pharmaceutical CMC area.

Papers:

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing


Individuals

2010 Annual Meeting
AIChE Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $225.00
Comprehensive Quality by Design in Pharmaceutical Development and Manufacture only
AIChE Members $100.00
AIChE Food, Pharmaceutical & Bioengineering Division Members Free
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $150.00